Publications

397 - 2014 Current-Drug-Development-Paradigm-Mestre-Ferrandiz-2014-LARGE

The Current Drug Development Paradigm: Responding to US and European Demands for Evidence of Comparative Effectiveness and Relative Effectiveness

1 April 2014

The project reported in this Occasional Paper was intended to determine how changing demands for evidence are affecting drug development in five global pharmaceutical companies: Amgen,…

398 - 2014 Real-Option-Value-Cook-Jul2015

Real Option Value and Path Dependence in Oncology Innovation

1 April 2014

Based on an OHE Lunchtime Seminar, this publication addresses a persistent issue: how to adequately reward innovation through the pricing of new medicines given the limitations…

395 - 2014 Can-the-US-Afford-Chambers-2014-BIG

Can the US Afford to Ignore Cost-effectiveness Evidence?

1 March 2014

Cost-effectiveness analysis plays a limited role in US health care compared to many other countries. In this Seminar Briefing, Dr James Chambers, Center for the Evaluation…

394 - Projecting_NHS_expend_Jan_2014

Projecting Expenditure on Medicines in the NHS: Second Edition

1 January 2014

The Pharmaceutical Price Regulation Scheme (PPRS) 2014 Heads of Agreement, announced on 6 November 2013, outlines the terms of the five-year deal between the pharmaceuctical industry…

393 - Contracting-for-Quality-Maynard-2014

Contracting for Quality in the NHS

1 January 2014

This monograph, based on Professor Maynard’s remarks at the 20th OHE Annual Lecture, explores the critical issue of ensuring the quality of care in the NHS.…

Cracks through the ice on a melting glacier in Alaska

Searching for Cost-effectiveness Thresholds in NHS Scotland

1 December 2013

This research examines the use of QALY thresholds in NHS Scotland in 2012-13 for health services that were “at the margin”, i.e. those for which investment or…

Cracks through the ice on a melting glacier in Alaska

Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold

12 January 2013

This paper counters the recently-published recommendation by Claxton et al[1] that NICE should lower its cost-per-QALY threshold from the current £20,000–£30,000 official range to £12,936. The…

390 - Influence-of-cost-effectiveness-NICE-Dakin-2013-NEW

The Influence of Cost-effectiveness and Other Factors on NICE Decisions

1 November 2013

In this Research Paper, the authors explore which factors have most influenced NICE decisions from 1999 through the end of 2011. The research has two objectives:…

OHE-Guide-to-UK-Health-Care-Statistics-Hawe-2013-BIG

OHE Guide to UK Health and Health Care Statistics

1 October 2013

This publication provides both up-to-date statistics and a guide to finding and using health statistics from the UK and, to some extent, other OECD countries. Data…